Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 9 | 13 | +2,52 % | ||
| IMMUNITYBIO | 8 | 3 | +14,16 % | ||
| BRIDGEBIO PHARMA | 6 | - | +1,06 % | ||
| ALNYLAM PHARMACEUTICALS | 4 | 9 | +1,03 % | ||
| DISC MEDICINE | 3 | 7 | 0,00 % | ||
| KYMERA THERAPEUTICS | 2 | 6 | 0,00 % | ||
| ANI PHARMACEUTICALS | 2 | 5 | -2,03 % | ||
| APELLIS PHARMACEUTICALS | 2 | 4 | -0,97 % | ||
| PHATHOM PHARMACEUTICALS | 2 | 2 | 0,00 % | ||
| STRUCTURE THERAPEUTICS | 2 | 1 | 0,00 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13:42 | Sobi, Apellis win EU nod for Aspaveli against rare kidney diseases | - | Seeking Alpha | ||
| 13:42 | Goldman Sachs upgrades BioNTech stock to Buy on oncology potential | - | Investing.com | ||
| 13:42 | Cantor Fitzgerald reiterates Overweight rating on Vera Therapeutics stock | - | Investing.com | ||
| 13:35 | Moderna's Q4 2025 Earnings: What to Expect | 4 | Barchart.com | ||
| 13:30 | Guggenheim raises ANI Pharmaceuticals stock price target on Cortrophin outlook | 2 | Investing.com | ||
| 13:30 | Guggenheim raises MBX Biosciences stock price target on obesity drug potential | 5 | Investing.com | ||
| 13:24 | ImmunityBio shares climb as bladder cancer trial nears full enrollment, BLA submission expected by year-end | 3 | Seeking Alpha | ||
| 13:22 | MESOBLAST LTD - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 13:06 | EyePoint Pharmaceuticals, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| 13:06 | ImmunityBio's bladder cancer trial enrollment at 85%, BLA filing planned | 5 | Investing.com | ||
| 13:06 | AtaiBeckley N.V.: AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation | 5 | GlobeNewswire (USA) | ||
| 12:03 | Sanofi - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 11:06 | BridgeBio Pharma prices $550M convertible bond offering | 3 | Seeking Alpha | ||
| 10:38 | ANAVEX LIFE SCIENCES CORP - Jetzt kippt das Momentum! | 2 | Maximilian Berger | ||
| 10:31 | Morgen-Update: Alarm bei Biontech: Verkauft der Markt jetzt gnadenlos ab? | Hebelschein-Spekulant | |||
| 08:30 | UBS downgrades Sanofi stock rating to Neutral on pipeline concerns | 32 | Investing.com | ||
| 07:46 | BridgeBio Pharma bepreist Wandelanleihe über 550 Millionen US-Dollar | 5 | Investing.com Deutsch | ||
| 07:29 | ImmunityBio Shares Jump On Significant Product Revenue Growth | 40 | RTTNews | ||
| 07:29 | BridgeBio Pharma Prices $550 Mln Of 0.75% Convertible Senior Notes Due 2033 | 1 | RTTNews | ||
| 07:22 | BridgeBio platziert Wandelanleihe über 550 Mio. US-Dollar mit 0,75 % Kupon | 5 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .